These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8290554)

  • 21. Regulation of thromboxane receptor activation in human platelets.
    Murray R; FitzGerald GA
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):124-8. PubMed ID: 2521385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased cytosolic phospholipase A2 activity is not accompanied by arachidonic acid liberation in U46619-stimulated rabbit platelets.
    Akiba S; Abe T; Sato T
    Biochem Mol Biol Int; 1995 Feb; 35(2):275-81. PubMed ID: 7663381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstitution of thromboxane A2 receptor-stimulated phosphoinositide hydrolysis in isolated platelet membranes: involvement of phosphoinositide-specific phospholipase C-beta and GTP-binding protein Gq.
    Baldassare JJ; Tarver AP; Henderson PA; Mackin WM; Sahagan B; Fisher GJ
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):235-40. PubMed ID: 8385934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of Gz in human platelets. Selectivity and site of modification.
    Lounsbury KM; Casey PJ; Brass LF; Manning DR
    J Biol Chem; 1991 Nov; 266(32):22051-6. PubMed ID: 1939224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase.
    Wang GR; Zhu Y; Halushka PV; Lincoln TM; Mendelsohn ME
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4888-93. PubMed ID: 9560198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N; Mais DE; Halushka PV
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin.
    Brass LF; Shaller CC; Belmonte EJ
    J Clin Invest; 1987 Apr; 79(4):1269-75. PubMed ID: 3031135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
    Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor occupancy regulates Ca2+ entry and intracellular Ca2+ redistribution in activated human platelets.
    Brüne B; von Appen F; Ullrich V
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):993-9. PubMed ID: 7818507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
    Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
    Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
    Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Gq and G12 families of heterotrimeric G proteins report functional selectivity.
    Zhang L; Brass LF; Manning DR
    Mol Pharmacol; 2009 Jan; 75(1):235-41. PubMed ID: 18952767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-ethylmaleimide inhibits platelet aggregation and potentiates hydrogen peroxide formation induced by thrombin.
    Leoncini G
    Biochem Mol Biol Int; 1994 Aug; 34(1):119-26. PubMed ID: 7849614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of the voltage-gated K+ current of human megakaryocytes by thrombin and prostacyclin.
    Kapural L; Fein A
    Biochim Biophys Acta; 1997 Mar; 1355(3):331-42. PubMed ID: 9061004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.